Unfortunately, some tables and figures were missing in the original version. The missing tables and figures are presented below.

Table [1](#Tab1){ref-type="table"}: Baseline study population characteristics

Figure [1](#Fig1){ref-type="fig"}: Differences in Baseline Characteristics

Table [2](#Tab2){ref-type="table"}: Discharge medications

Table [3](#Tab3){ref-type="table"}: Outcome

Table [4](#Tab4){ref-type="table"}: Univaraible predictors of mortality or rehospitalization

Table [5](#Tab5){ref-type="table"}: Multivariable predictors of mortality or rehospitalization by gender

Table [6](#Tab6){ref-type="table"}: Multivariate predictors of mortality or rehospitalization by LVEF

Table 1:Baseline study population characteristicsWomen (n=2635)Men (n=3068)P-value**Mean age, year**73.167.4\< 0.001**Hypertension, %**78.672.1\< 0.001**Diabetes, %**55.750.2\< 0.001**CAD, %**33.841.0\< 0.001**Prior MI, %**14.919.8\< 0.001**PVD, %**4.75.20.343**Current smoker, %**3.722.7\< 0.001**Fatigue, %**19.518.20.202**Rales, %**70.668.40.080**Peripheral edema, %**67.064.70.070**Mean SBP, mmHg**147± 30142 ± 39\< 0.001**Mean HR, bpm**89 ± 2491 ± 230.038**% A-fib/flutter**22.218.1\< 0.001**Mean Na, mmol/L**137±6137±220.356**Median sCr, umol/L**99 (74, 144)117 (94, 159)\< 0.001**Median BUN, mmol/L**6.8 (5, 10)7.0 (5, 10)0.372**Median Hb, g/dL**11.5 (10, 13)12.9 (11, 45)\< 0.001**Anemia, %**59.651.2\< 0.001**LVEF ≥ 50%**42.520.8\< 0.001**Initial ED care, %**94.793.80.473**General ward care, %**92.090.20.144**Mechanical ventilation, %**1.21.60.223**Dialysis, %**0.20.30.575**Coronary angiography, %**1.42.8\<0.001**CPR, %**0.70.70.869CAD, coronary artery disease; LVEF, left ventricular ejection fraction; PVD, peripheral disease; SBP, systolic blood pressure; ED, emergency departmentvascular, CPR, cardiopulmonary resuscitation. Data are mean ± SD or median (25^th^, 75^th^ percentile).

Table 2.Discharge medications**Discharge medicationsAll patientsPreserved LVEFReduced LVEFWomen**\
**(n=2635)Men**\
**(n=3068)P-valueWomen**\
**(n=1119)Men**\
**(n=638)P-valueWomen**\
**(n=1516)Men**\
**(n=2430)P-valueACEI, %**46.858.3\< 0.00142.652.7\< 0.00149.859.8\<0.001**ARB, %**20.114.9\< 0.00121.515.80.00419.114.7\<0.001**ACEI or ARB, %**65.471.9\< 0.00162.260.00.98467.773.4\<0.001**Aldosterone antagonist, %**9.515.7\< 0.0015.05.00.99212.918.6\<0.001**Loop diuretics, %**80.184.1\< 0.00175.477.60.30683.585.80.050**Nitrates, %**30.033.5\< 0.00129.832.90.18130.133.80.017**Digoxin, %**23.227.5\< 0.00120.818.80.31125.029.80.001**Beta-blocker, %**57.864.2\< 0.00153.656.60.23060.966.20.001ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker.

Table 3.Outcome**OutcomeAll patientsPreserved LVEFReduced LVEFWomenMenP-valueWomenMenP-valueWomenMenP-value(n=2635)(n=3068)(n=1119)(n=638)(n=1516)(n=2430)Mean Length of stay, d**5.625.05\<0.0015.775.170.0215.515.020.009**In-hospital Mortality, %**1.91.70.6382.11.40.3311.71.80.899**Rehospitalization, %**26.226.30.92023.621.00.14424.825.50.623

Table 4:Univaraible predictors of mortality or rehospitalizationWomen (n=2635)Men (n=3068)**Risk Factors**HR (95% CI)P-valueHR (95% CI)P-value**Log Age**4.41 (2.00-9.71)\<0.0014.90 (2.49-9.61)\<.001**LVEF \<50%**0.79 (0.70-0.90)\<0.0010.75 (0.65-0.87)\<.001**Renal Disorder**1.55 (1.35-1.77)\<0.0011.39 (1.22-1.58)\<0.001**HTN**0.96 (0.83-1.11)0.6181.00 (0.88-1.13)0.983**CAD**1.25 (1.11-1.42)\<.0011.13 (1.01-1.27)0.028**Prior MI**1.49 (1.28-1.73)\<.0011.36 (1.19-1.55)\<.001**Diabetes**1.25 (1.10-1.41)\<.0011.12 (1.00-1.25)0.046**PVD**1.47 (1.13-1.91)0.0041.60 (1.28-1.99)\<.001**Prior CVA/TIA**1.31(1.22-1.53)0.0011.19 (1.02-1.38)0.029**Current smoker**0.75 (0.53-1.07)0.1090.92 (0.80-1.05)0.210**COPD**1.07 (0.88-1.11)0.5051.10 (0.93-1.30)0.261**Hyperlipidemia**1.10 (0.98-1.25)0.1171.03 (0.92-1.16)0.565**Atrial Fibrillation**1.20 (1.05-1.38)0.0081.05 (0.92-1.21)0.467**Peripheral edema**1.09 (0.96-1.24)0.1991.05 (0.93-1.18)0.460**Anemia**1.36 (1.20-1.55)\<.0011.47 (1.31-1.65)\< .001**Discharge ACEI or ARB**0.71 (0.63-0.80)\<.0010.68 (0.60-0.76)\< .001**Discharge beta-blocker**0.84 (0.74-0.95)0.0040.73 (0.65-0.81)\< .001**Discharge Aspirin**0.78 (0.69-0.88)\< .0010.83 (0.74-0.93)0.001**Discharge lipid-lowering**0.82 (0.72-0.92)0.0010.81 (0.72-0.91)\< .001**Discharge loop diuretics**0.91 (0.78-1.06)0.2100.71 (0.62-0.82)\< .001CAD, coronary artery disease; LVEF, left ventricular ejection fraction; HTN, hypertension; MI, myocardial infarction; PVD, peripheral disease; CVA, cerebralvascular accident; TIA, transient ischemic attack; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker.

Table 5:Multivariable predictors of mortality or rehospitalization by genderWomen (n=2,635)Men (n=3,068)**HR (95% CI)P-valueHR (95% CI)P-valueAge**1.01 (1.00-1.02)0.0021.01 (1.00-1.02)0.01**Renal Disorder**1.42 (1.12-1.80)0.0041.10 (0.89-1.37)0.37**Prior MI**1.69 (1.34-2.13)\<0.0011.64 (1.35-1.99)\<0.001**Afib**1.28 (1.05-1.55)0.0161.19 (0.97-1.46)0.10**Diabetes**1.27 (1.06-1.53)0.0101.08 (0.91-1.27)0.38**PVD**1.01 (0.68-1.50)0.971.32 (0.93-1.85)0.12**LVEF \< 50**1.20 (1.01-1.44)0.041.54 (1.26-1.89)\<0.001**Hypertension**0.83 (0.67-1.03)0.090.93 (0.77-1.13)0.47**Anemia**1.12 (0.94-1.34)0.201.42 (1.20-1.67)\<0.001**Discharge Beta Blocker**0.79 (0.66-0.94)0.0070.65 (0.55-0.77)\<0.001**Discharge ACE/ARB**0.78 (0.65-0.94)0.0070.76 (0.63-0.90)0.002LVEF, left ventricular ejection fraction; Afi b, atrial fi brillation; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker.

Table 6.Multivariate predictors of mortality or rehospitalization by LVEFNormal EFAbnormal EFHR (95% CI)P-valueHR (95% CI)P-value**Age**1.01 (1.00-1.02)0.0191.01 (1.00-1.01)\<0.001**Sex**1.22 (0.98-1.53)0.0790.98 (0.83-1.13)0.738**Renal Disorder**1.42 (1.06-1.90)0.0191.17 (0.97-1.42)0.104**Prior MI**1.95 (1.43-2.66)\<0.0011.56 (1.31-1.84)\<0.001**Prior CVA**1.07 (0.82-1.40)0.6311.25 (1.03-1.51)0.026**Afib**1.30 (1.04-1.64)0.0241.18 (0.99-1.31)0.072**Diabetes**1.04 (0.82-1.31)0.7331.21 (1.05-1.41)0.011**Hypertension**0.70 (0.53-0.93)0.0120.98 (0.83-1.15)0.760**Admission BUN**1.06 (1.03-1.09)\<0.0011.06 (1.04-1.08)\<0.001**Anemia**1.19 (0.96-1.49)0.1171.30 (1.13-1.51)\<0.001**Discharge Beta Blocker**0.80 (0.65-1.00)0.0450.68 (0.59-0.78)\<0.001**Discharge ACEI or ARB**0.76 (0.61-0.95)0.0150.79 (0.67-0.92)0.003MI, myocardial infarction; CVA, cerebralvascular accident; CVA, cerebralvascular accident; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker.

The online version of the original article can be found at <http://dx.doi.org/10.7603/s40602-014-0008-y>
